title: Quantitative and Qualitative Research in HSDD: The Difference Between Testing Theory and Generating New Theories.
abstract: Tiefer (2017) criticized our recent analysis of psychological treatment trials for HSDD (Pyke & Clayton, 2015) on what she claims to be scientific and "political" grounds. In the same letter, she alleged that we, and, by extension, the U.S. Food and Drug Administration, promoted drugs to the detriment of psychological treatment of female sexual problems. Such accusations require a serious response.
authors.affiliation: a Department of Psychiatry , University of Virginia Health System , Charlottesville , Virginia , USA.
authors.forename: Anita H
authors.initials: AH
authors.lastname: Clayton
authors.affiliation: b Pykonsult, LLC , New Fairfield , Connecticut , USA.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Pyke
mesh_terms: D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D006801:Humans; D007989:Libido; D008962:Models, Theoretical; D020018:Sexual Dysfunctions, Psychological / Q000175:diagnosis* / Q000628:therapy*; D016387:Women's Health